跳至主要内容
临床试验/2026-526995-22-00
2026-526995-22-00招募中3 期

Antibiotikapenetration og vævsrespons ved infektion og rekonstruktiv kirurgi i hoved-hals regionen

Region Midtjylland1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2026年8月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
16
试验地点
1
主要终点
T>MIC for all investigated antibiotics in the measured tissues and in plasma, calculated based on concentration–time profiles obtained from microdialysate samples and serial blood sampling. T>MIC will be calculated using predefined MIC target values for each IMP in the primary analysis: cefuroxime 4 mg/L, cloxacillin 2 mg/L, dicloxacillin 2 mg/L, and amoxicillin/clavulanic acid 2 mg/L, expressed as the amoxicillin component.

研究概览

简要总结

To determine antibiotic exposure in tissue and plasma during treatment with selected antibiotics

研究设计

分配方式
Non Randomized
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • Signed informed consent
  • Either postoperative neck infection or planned reconstruction with an inferior turbinate flap (IFT flap)
  • Age above 18 years

排除标准

  • Known allergy or hypersensitivity to the administered antibiotics (cefuroxime, cloxacillin, dicloxacillin, or amoxicillin/clavulanic acid)
  • Pregnancy or planned pregnancy
  • eGFR <30 ml/min/1,73 m²

结局指标

主要结局

T>MIC for all investigated antibiotics in the measured tissues and in plasma, calculated based on concentration–time profiles obtained from microdialysate samples and serial blood sampling. T>MIC will be calculated using predefined MIC target values for each IMP in the primary analysis: cefuroxime 4 mg/L, cloxacillin 2 mg/L, dicloxacillin 2 mg/L, and amoxicillin/clavulanic acid 2 mg/L, expressed as the amoxicillin component.

T>MIC for all investigated antibiotics in the measured tissues and in plasma, calculated based on concentration–time profiles obtained from microdialysate samples and serial blood sampling. T>MIC will be calculated using predefined MIC target values for each IMP in the primary analysis: cefuroxime 4 mg/L, cloxacillin 2 mg/L, dicloxacillin 2 mg/L, and amoxicillin/clavulanic acid 2 mg/L, expressed as the amoxicillin component.

次要结局

  • Pharmacokinetic parameters (Cmax, AUC, Tmax and T½) in tissue and plasma
  • Concentrations of glucose, lactate, pyruvate and glycerol, as well as inflammatory proteins, in microdialysate samples

研究者

发起方
Region Midtjylland
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Tejs Ehlers Klug

Scientific

Region Midtjylland

研究点 (1)

Loading locations...

相似试验